Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.3 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 49.32.
Market Cap
9.3T
Revenue
4.67T
Profits
188.6B
PE Ratio
49.32
Profit Margin
4.04%
Dividend Yield
0.39%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | 3.62% | 3,167,444 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 611.90B | 2.13% | 9,662,030 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 500.94B | 3.32% | 5,633,169 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 363.59B | 3.80% | 9,807,791 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 355.11B | 4.73% | 7,774,997 | 450.06B |
| 6 | NVS | Novartis AG | 277.86B | 3.14% | 1,647,420 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.87B | 3.99% | 3,333,925 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 248.91B | 1.53% | 2,486,647 | 46.34B |
| 9 | AMGN | Amgen Inc. | 230.37B | 3.21% | 3,085,121 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 190.38B | 3.80% | 5,761,036 | 30.46B |
| 11 | ABT | Abbott Laboratories | 178.18B | 0.35% | 7,286,701 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 168.42B | 0.16% | 9,363,629 | 50.34B |
| 13 | PFE | Pfizer Inc. | 166.49B | 2.96% | 39,370,506 | 63.70B |
| 14 | DHR | Danaher Corporation | 157.95B | 0.83% | 3,596,733 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 148.46B | -0.43% | 1,915,622 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 126.35B | 2.74% | 2,090,487 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.09B | 4.61% | 14,053,901 | 49.19B |
| 18 | CVS | CVS Health Corporation | 115.61B | 3.24% | 9,334,720 | 412.65B |
| 19 | MDT | Medtronic plc | 115.35B | 1.31% | 49,863,654 | 37.54B |
| 20 | MCK | McKesson Corporation | 113.86B | 1.53% | 769,076 | 410.98B |
| 21 | SYK | Stryker Corporation | 108.02B | -0.33% | 2,228,464 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 101.85B | 2.10% | 1,081,461 | 78.01B |
| 23 | SNY | Sanofi | 95.70B | 1.66% | 5,335,394 | 55.89B |
| 24 | GSK | GSK plc | 95.69B | 3.46% | 7,088,059 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 92.84B | 0.66% | 2,116,185 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 90.35B | 4.65% | 16,625,368 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 77.72B | 3.35% | 879,091 | 15.53B |
| 28 | CI | The Cigna Group | 76.52B | 2.50% | 1,396,583 | 282.38B |
| 29 | COR | Cencora, Inc. | 64.15B | 1.84% | 1,187,188 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 62.32B | -0.72% | 15,103,219 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.20B | 2.65% | 4,677,035 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 57.37B | 3.35% | 1,972,928 | 254.25B |
| 33 | NTRA | Natera, Inc. | 56.90B | -0.23% | 1,047,648 | 2.71B |
| 34 | ARGX | argenx SE | 51.90B | 1.95% | 464,121 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 51.45B | 0.81% | 1,647,553 | 22.48B |
| 36 | HUM | Humana Inc. | 51.32B | 1.67% | 1,109,625 | 145.68B |
| 37 | EW | Edwards Lifesciences Corporation | 49.83B | 1.38% | 4,036,661 | 6.51B |
| 38 | A | Agilent Technologies, Inc. | 49.06B | 1.40% | 2,371,719 | 7.37B |
| 39 | VEEV | Veeva Systems Inc. | 48.14B | -1.42% | 1,240,203 | 3.46B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.45B | -1.28% | 10,270,567 | 17.32B |
| 41 | MDLN | Medline Inc. | 47.24B | 0.64% | 4,637,887 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 43.13B | 0.51% | 1,117,651 | 16.98B |
| 43 | WAT | Waters Corporation | 42.90B | 1.73% | 901,578 | 4.64B |
| 44 | HLN | Haleon plc | 41.94B | 2.54% | 13,842,012 | 14.80B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 41.68B | 1.67% | 824,669 | 4.55B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.48B | 2.70% | 2,463,047 | - |
| 47 | ILMN | Illumina, Inc. | 41.04B | 0.21% | 2,120,760 | 4.49B |
| 48 | ONC | BeOne Medicines AG | 39.96B | 0.69% | 361,614 | 6.13B |
| 49 | CNC | Centene Corporation | 34.66B | 1.89% | 4,927,494 | 180.30B |
| 50 | BIIB | Biogen Inc. | 34.40B | 1.72% | 1,947,327 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 33.92B | 4.28% | 2,828,242 | 2.54B |
| 52 | RMD | ResMed Inc. | 33.09B | 0.11% | 1,020,695 | 5.65B |
| 53 | MTD | Mettler-Toledo International Inc. | 32.24B | 0.70% | 287,040 | 4.13B |
| 54 | DXCM | DexCom, Inc. | 31.50B | -1.87% | 3,481,314 | 4.97B |
| 55 | ZTS | Zoetis Inc. | 31.11B | 1.33% | 4,158,693 | 9.53B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 30.93B | -0.47% | 5,034,550 | 21.27B |
| 57 | ALC | Alcon Inc. | 30.75B | 1.38% | 1,718,459 | 10.86B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.04B | 0.29% | 1,105,653 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.37B | 0.76% | 444,574 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.76B | 1.29% | 1,201,551 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.74B | 1.18% | 573,571 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 24.43B | 0.44% | 1,105,840 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.28B | 0.81% | 4,293,777 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.16B | -0.62% | 883,183 | 3.15B |
| 65 | INCY | Incyte Corporation | 22.61B | 2.72% | 1,870,089 | 5.82B |
| 66 | BNTX | BioNTech SE | 22.27B | -0.39% | 1,130,717 | 3.03B |
| 67 | GMAB | Genmab A/S | 22.06B | 0.88% | 2,687,476 | 4.13B |
| 68 | GH | Guardant Health, Inc. | 21.87B | 0.56% | 1,278,818 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.87B | 1.76% | 717,346 | 21.81B |
| 70 | INSM | Insmed Incorporated | 21.36B | 1.03% | 2,737,093 | 1.14B |
| 71 | STE | STERIS plc | 21.18B | -0.23% | 587,199 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.03B | 1.10% | 8,682,544 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.50B | -0.34% | 1,890,236 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.21B | 1.11% | 311,259 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.97B | -1.91% | 2,023,247 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.11B | 2.49% | 2,753,065 | 2.44B |
| 77 | ASND | Ascendis Pharma A/S | 14.91B | 1.70% | 995,684 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.85B | 1.11% | 1,031,177 | 8.31B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.42B | 1.00% | 941,768 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.82B | 0.58% | 1,506,704 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.61B | -0.35% | 891,561 | 4.60B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 13.26B | 6.57% | 3,770,015 | 1.66B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.20B | 1.12% | 1,384,626 | 14.37B |
| 84 | ICLR | ICON Public Limited Company | 13.04B | 2.82% | 629,664 | 8.29B |
| 85 | BAX | Baxter International Inc. | 12.82B | -0.36% | 5,209,624 | 11.47B |
| 86 | BBIO | BridgeBio Pharma, Inc. | 12.70B | 2.59% | 2,701,563 | 713.07M |
| 87 | PEN | Penumbra, Inc. | 12.61B | 0.03% | 272,341 | 1.50B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.56B | -1.33% | 691,964 | 830.81M |
| 89 | EHC | Encompass Health Corporation | 12.49B | 1.79% | 737,679 | 6.21B |
| 90 | TEM | Tempus AI, Inc. | 12.33B | 0.15% | 6,064,833 | 1.43B |
| 91 | SMMT | Summit Therapeutics Inc. | 12.10B | -2.51% | 4,661,711 | - |
| 92 | SNN | Smith & Nephew plc | 11.61B | 0.07% | 860,351 | 6.30B |
| 93 | DVA | DaVita Inc. | 11.52B | -0.76% | 444,595 | 14.01B |
| 94 | TECH | Bio-Techne Corporation | 11.37B | 0.03% | 1,544,855 | 1.22B |
| 95 | FMS | Fresenius Medical Care AG | 11.30B | 2.18% | 1,214,958 | 22.19B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.27B | 0.62% | 4,942,920 | 5.02B |
| 97 | UHS | Universal Health Services, Inc. | 10.96B | 3.84% | 656,343 | 18.11B |
| 98 | MOH | Molina Healthcare, Inc. | 10.90B | -0.15% | 1,225,455 | 42.47B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 1.40% | 1,845,709 | 3.41B |
| 100 | PCVX | Vaxcyte, Inc. | 10.63B | 1.12% | 1,525,370 | - |
| 101 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.63B | 1.75% | 326,944 | 1.28B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.63B | -0.16% | 3,738,871 | 3.50B |
| 103 | AVTR | Avantor, Inc. | 10.62B | 0.96% | 8,051,745 | 6.56B |
| 104 | OSCR | Oscar Health, Inc. | 10.58B | 1.57% | 5,285,262 | 15.32B |
| 105 | IBRX | ImmunityBio, Inc. | 10.50B | 1.12% | 30,228,562 | 165.79M |
| 106 | COO | The Cooper Companies, Inc. | 10.44B | 0.53% | 3,412,334 | 4.24B |
| 107 | ALGN | Align Technology, Inc. | 10.26B | 0.63% | 718,425 | 4.14B |
| 108 | GMED | Globus Medical, Inc. | 10.25B | -0.01% | 1,059,620 | 3.14B |
| 109 | ENSG | The Ensign Group, Inc. | 10.16B | 1.49% | 292,373 | 5.49B |
| 110 | RGEN | Repligen Corporation | 10.06B | 1.58% | 1,216,922 | 785.10M |
| 111 | GKOS | Glaukos Corporation | 9.90B | 1.44% | 624,167 | 612.84M |
| 112 | KRYS | Krystal Biotech, Inc. | 9.79B | 2.97% | 277,537 | 440.48M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.69B | -0.36% | 297,397 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.54B | 0.62% | 1,116,065 | 13.60B |
| 115 | TXG | 10x Genomics, Inc. | 9.52B | 1.82% | 4,139,000 | 616.91M |
| 116 | QGEN | Qiagen N.V. | 9.42B | 0.26% | 1,632,436 | 2.10B |
| 117 | TWST | Twist Bioscience Corporation | 9.29B | -2.09% | 2,122,701 | 431.80M |
| 118 | PODD | Insulet Corporation | 9.29B | -3.04% | 2,318,441 | 3.05B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.88B | 0.14% | 1,029,093 | 105.00M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.82B | -1.60% | 679,101 | 281.99M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.82B | 2.94% | 2,095,778 | 67.67M |
| 122 | CAI | Caris Life Sciences, Inc. | 8.55B | 2.46% | 4,347,421 | 989.61M |
| 123 | AXSM | Axsome Therapeutics, Inc. | 8.50B | 3.77% | 893,237 | 776.57M |
| 124 | HNGE | Hinge Health, Inc. | 8.47B | -0.13% | 1,624,816 | 720.06M |
| 125 | BRKR | Bruker Corporation | 8.47B | -1.05% | 2,335,518 | 3.50B |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.25B | 0.41% | 4,160,278 | 669.50M |
| 127 | TGTX | TG Therapeutics, Inc. | 7.71B | 0.06% | 1,286,421 | 799.54M |
| 128 | ABVX | ABIVAX Société Anonyme | 7.68B | 2.04% | 1,126,613 | 5.33M |
| 129 | ATR | AptarGroup, Inc. | 7.65B | 0.89% | 452,111 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.43B | -0.35% | 820,356 | 1.36B |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.35B | -2.26% | 1,624,639 | - |
| 132 | PACS | PACS Group, Inc. | 7.12B | 1.35% | 456,446 | 5.55B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.10B | 0.76% | 2,027,743 | 874.09M |
| 134 | CHE | Chemed Corporation | 6.68B | 2.48% | 129,945 | 2.60B |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 6.67B | -1.78% | 958,761 | 7.46M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.58B | -3.42% | 3,963,917 | 3.12B |
| 137 | ALKS | Alkermes plc | 6.56B | -1.64% | 1,551,181 | 1.67B |
| 138 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.02% | 936,669 | 1.56B |
| 139 | GRFS | Grifols, S.A. | 6.50B | 0.98% | 538,498 | 8.48B |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.47B | -6.70% | 11,071,763 | 2.58B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | -2.00% | 10,626,272 | 324.97M |
| 142 | GRAL | GRAIL, Inc. | 6.24B | -0.46% | 826,630 | 165.26M |
| 143 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.15B | 0.39% | 576,559 | 840.85M |
| 144 | BLTE | Belite Bio, Inc | 6.15B | 0.56% | 158,497 | - |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.97B | 0.12% | 585,836 | 239.92M |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | -2.81% | 245,284 | 290.54M |
| 147 | IMVT | Immunovant, Inc. | 5.76B | -2.82% | 1,773,520 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 5.73B | 1.45% | 486,312 | 5.32B |
| 149 | HAE | Haemonetics Corporation | 5.51B | -0.50% | 592,145 | 1.35B |
| 150 | CGON | CG Oncology, Inc. | 5.48B | -0.90% | 1,100,489 | 6.23M |
| 151 | RDNT | RadNet, Inc. | 5.44B | -3.29% | 477,922 | 2.27B |
| 152 | DOCS | Doximity, Inc. | 5.33B | -2.06% | 2,693,496 | 655.57M |
| 153 | STVN | Stevanato Group S.p.A. | 5.27B | 0.26% | 360,566 | 1.40B |
| 154 | TFX | Teleflex Incorporated | 5.22B | -0.92% | 706,507 | 2.25B |
| 155 | MMSI | Merit Medical Systems, Inc. | 5.20B | -1.11% | 608,007 | 1.58B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.19B | 0.43% | 975,117 | 618.07M |
| 157 | WAY | Waystar Holding Corp. | 5.15B | 2.17% | 3,726,074 | 1.21B |
| 158 | ERAS | Erasca, Inc. | 5.14B | -0.54% | 4,747,561 | - |
| 159 | KOD | Kodiak Sciences Inc. | 5.09B | -11.50% | 2,406,536 | - |
| 160 | ORKA | Oruka Therapeutics, Inc. | 5.08B | -1.93% | 685,301 | - |
| 161 | SHC | Sotera Health Company | 5.06B | -2.64% | 2,279,717 | 1.22B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.02B | 2.84% | 2,061,180 | 591.33M |
| 163 | PTCT | PTC Therapeutics, Inc. | 4.98B | -0.42% | 1,519,818 | 1.01B |
| 164 | COGT | Cogent Biosciences, Inc. | 4.89B | 0.21% | 2,295,508 | - |
| 165 | CRSP | CRISPR Therapeutics AG | 4.86B | 0.24% | 1,707,557 | 13.39M |
| 166 | SRRK | Scholar Rock Holding Corporation | 4.82B | -2.27% | 1,278,097 | - |
| 167 | LFST | LifeStance Health Group, Inc. | 4.78B | 1.62% | 3,444,661 | 1.58B |
| 168 | CON | Concentra Group Holdings Parent, Inc. | 4.78B | -0.21% | 2,525,702 | 2.29B |
| 169 | MANE | Veradermics, Incorporated | 4.74B | -2.40% | 487,644 | - |
| 170 | MMED | MiniMed Group, Inc. | 4.73B | -8.64% | 67,627,677 | 3.22B |
| 171 | OPCH | Option Care Health, Inc. | 4.66B | 0.06% | 4,931,457 | 5.69B |
| 172 | BLLN | BillionToOne, Inc. | 4.62B | 3.64% | 424,933 | 397.41M |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.60B | -0.41% | 1,762,182 | - |
| 174 | ITGR | Integer Holdings Corporation | 4.30B | 0.02% | 680,854 | 1.84B |
| 175 | HTFL | HeartFlow, Inc. | 4.30B | -1.71% | 1,616,350 | 212.07M |
| 176 | LIVN | LivaNova PLC | 4.19B | -0.38% | 464,614 | 1.47B |
| 177 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | -3.63% | 977,334 | 1.90M |
| 178 | ADPT | Adaptive Biotechnologies Corporation | 4.09B | 1.34% | 1,884,114 | 308.08M |
| 179 | ICUI | ICU Medical, Inc. | 4.07B | -0.33% | 258,441 | 2.16B |
| 180 | INDV | Indivior Pharmaceuticals, Inc. | 4.03B | -3.56% | 2,781,192 | 1.33B |
| 181 | RGC | Regencell Bioscience Holdings Limited | 4.02B | -0.98% | 657,996 | - |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 4.02B | 2.04% | 1,446,129 | - |
| 183 | ABCL | AbCellera Biologics Inc. | 4.01B | -1.90% | 3,058,826 | 66.17M |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.74B | -0.14% | 3,438,789 | 53.81M |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.74B | -1.73% | 2,936,798 | 10.35M |
| 186 | LEGN | Legend Biotech Corporation | 3.69B | 6.49% | 3,535,755 | 1.27B |
| 187 | NHC | National HealthCare Corporation | 3.67B | 1.34% | 80,773 | 1.56B |
| 188 | NVST | Envista Holdings Corporation | 3.67B | 0.75% | 1,988,488 | 2.86B |
| 189 | OGN | Organon & Co. | 3.61B | -0.22% | 1,808,055 | 6.13B |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.57B | -2.47% | 223,277 | 890.79M |
| 191 | VCYT | Veracyte, Inc. | 3.50B | 0.93% | 935,354 | 561.90M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.50B | -1.54% | 482,611 | 825.34M |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.39B | 0.67% | 1,166,179 | -665.00K |
| 194 | CDNA | CareDx, Inc. | 3.35B | -1.13% | 1,191,630 | 458.09M |
| 195 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | 1.23% | 1,647,290 | 463.98M |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.32B | 3.38% | 1,642,771 | 1.14B |
| 197 | PLSE | Pulse Biosciences, Inc. | 3.30B | -4.57% | 440,297 | 1.19M |
| 198 | XENE | Xenon Pharmaceuticals Inc. | 3.28B | -1.51% | 1,787,875 | 7.50M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | -1.17% | 1,059,874 | 234.13M |
| 200 | PBLS | Parabilis Medicines, Inc. | 3.20B | -3.58% | 764,911 | 148.00K |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | 2.08% | 1,166,768 | 606.33M |
| 202 | WRBY | Warby Parker Inc. | 3.08B | -6.03% | 3,071,027 | 911.61M |
| 203 | LQDA | Liquidia Corporation | 3.04B | 26.59% | 21,143,436 | 450.91M |
| 204 | VKTX | Viking Therapeutics, Inc. | 2.97B | -4.43% | 6,581,072 | - |
| 205 | ACHC | Acadia Healthcare Company, Inc. | 2.95B | 4.76% | 1,928,487 | 3.37B |
| 206 | CELC | Celcuity Inc. | 2.93B | -5.21% | 2,441,319 | - |
| 207 | ATRC | AtriCure, Inc. | 2.91B | 0.76% | 799,310 | 569.62M |
| 208 | ELVN | Enliven Therapeutics, Inc. | 2.88B | -0.53% | 1,217,094 | - |
| 209 | RCUS | Arcus Biosciences, Inc. | 2.87B | 0.09% | 1,211,972 | 117.00M |
| 210 | DNLI | Denali Therapeutics Inc. | 2.86B | -2.88% | 2,703,305 | 3.60M |
| 211 | DYN | Dyne Therapeutics, Inc. | 2.81B | -1.70% | 2,195,905 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.77B | 0.09% | 1,302,475 | 2.36B |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.70B | 1.48% | 2,028,421 | 2.60B |
| 214 | NEOG | Neogen Corporation | 2.65B | 3.41% | 3,354,152 | 884.00M |
| 215 | PGEN | Precigen, Inc. | 2.63B | -1.67% | 4,196,741 | 85.72M |
| 216 | TMDX | TransMedics Group, Inc. | 2.62B | -4.57% | 892,067 | 668.47M |
| 217 | NRIX | Nurix Therapeutics, Inc. | 2.59B | 6.96% | 3,821,055 | 701.94M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.57B | 1.93% | 390,669 | 1.46B |
| 219 | CLOV | Clover Health Investments, Corp. | 2.54B | -0.42% | 3,756,971 | 2.48B |
| 220 | ZLAB | Zai Lab Limited | 2.53B | -2.60% | 849,721 | 449.61M |
| 221 | HCM | HUTCHMED (China) Limited | 2.47B | -0.15% | 81,772 | 549.12M |
| 222 | BKD | Brookdale Senior Living Inc. | 2.41B | -0.10% | 3,502,402 | 2.93B |
| 223 | SLS | SELLAS Life Sciences Group, Inc. | 2.40B | -4.27% | 4,743,595 | - |
| 224 | NAMS | NewAmsterdam Pharma Company N.V. | 2.39B | -0.89% | 2,191,316 | 7.12M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.36B | -3.19% | 1,661,625 | 156.04M |
| 226 | MBX | MBX Biosciences, Inc. | 2.35B | -0.37% | 994,415 | - |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.34B | -4.36% | 906,716 | 830.44M |
| 228 | ADMA | ADMA Biologics, Inc. | 2.32B | 0.29% | 2,876,498 | 512.28M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | -0.21% | 683,969 | 1.10B |
| 230 | UFPT | UFP Technologies, Inc. | 2.25B | -1.08% | 152,910 | 631.64M |
| 231 | PRGO | Perrigo Company plc | 2.21B | 3.77% | 4,637,057 | 4.14B |
| 232 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.53% | 1,225,703 | 311.51M |
| 233 | BHC | Bausch Health Companies Inc. | 2.20B | - | 1,751,799 | 10.85B |
| 234 | CLDX | Celldex Therapeutics, Inc. | 2.19B | -1.47% | 1,044,323 | 158.00K |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | 1.30% | 972,241 | 959.90M |
| 236 | NEO | NeoGenomics, Inc. | 2.17B | 1.32% | 1,616,006 | 766.30M |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.15B | 1.69% | 1,156,429 | 1.95B |
| 238 | IRON | Disc Medicine, Inc. | 2.14B | -1.52% | 430,718 | - |
| 239 | PGNY | Progyny, Inc. | 2.14B | 1.64% | 774,076 | 1.31B |
| 240 | ADUS | Addus HomeCare Corporation | 2.13B | 1.82% | 249,666 | 1.48B |
| 241 | PHVS | Pharvaris N.V. | 2.11B | - | 400,429 | - |
| 242 | NVAX | Novavax, Inc. | 2.08B | -1.40% | 8,545,781 | 413.80M |
| 243 | VRDN | Viridian Therapeutics, Inc. | 2.08B | 0.88% | 3,733,884 | 71.13M |
| 244 | AXGN | Axogen, Inc. | 2.06B | -2.85% | 1,173,575 | 251.17M |
| 245 | VCEL | Vericel Corporation | 2.06B | -0.12% | 384,553 | 306.30M |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.06B | -0.25% | 5,649,889 | 940.61M |
| 247 | WGS | GeneDx Holdings Corp. | 2.05B | 5.62% | 962,131 | 454.43M |
| 248 | FTRE | Fortrea Holdings Inc. | 2.03B | 2.01% | 2,938,086 | 2.68B |
| 249 | BFLY | Butterfly Network, Inc. | 2.02B | -6.17% | 4,132,758 | 112.14M |
| 250 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | -2.48% | 18,783,664 | 54.86M |
| 251 | ADRX | ADARx Pharmaceuticals, Inc. | 2.00B | 0.73% | 285,475 | 6.13M |
| 252 | INSP | Inspire Medical Systems, Inc. | 1.97B | -1.15% | 855,154 | 898.74M |
| 253 | IMNM | Immunome, Inc. | 1.95B | -2.16% | 1,155,226 | 4.02M |
| 254 | ASTH | Astrana Health, Inc. | 1.93B | -0.40% | 446,094 | 3.84B |
| 255 | VERA | Vera Therapeutics, Inc. | 1.93B | -0.19% | 1,534,557 | - |
| 256 | SGRY | Surgery Partners, Inc. | 1.92B | 1.92% | 1,440,058 | 3.37B |
| 257 | TRLV | Trulieve Cannabis Corp. | 1.92B | -1.38% | 1,734,104 | 1.14B |
| 258 | LMAT | LeMaitre Vascular, Inc. | 1.89B | 1.31% | 316,035 | 262.43M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 1.20% | 226,585 | 1.13B |
| 260 | SDGR | Schrödinger, Inc. | 1.87B | -3.24% | 1,287,749 | 259.04M |
| 261 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | 2.52% | 930,896 | 98.34M |
| 262 | ALVO | Alvotech | 1.85B | -3.90% | 1,058,174 | 494.61M |
| 263 | MLYS | Mineralys Therapeutics, Inc. | 1.84B | -1.14% | 1,159,525 | - |
| 264 | URGN | UroGen Pharma Ltd. | 1.79B | -4.39% | 1,079,745 | 188.73M |
| 265 | XERS | Xeris Biopharma Holdings, Inc. | 1.78B | -4.22% | 2,367,072 | 335.41M |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 1.94% | 2,741,334 | 1.97B |
| 267 | PVLA | Palvella Therapeutics, Inc. | 1.77B | -4.61% | 384,515 | - |
| 268 | VIR | Vir Biotechnology, Inc. | 1.76B | -1.89% | 2,767,515 | 303.23M |
| 269 | ALMR | Alamar Biosciences, Inc. | 1.76B | 7.87% | 467,051 | 100.42M |
| 270 | ZYME | Zymeworks Inc. | 1.76B | -1.20% | 558,779 | 37.13M |
| 271 | MESO | Mesoblast Limited | 1.75B | -0.79% | 225,652 | 120.25M |
| 272 | XNCR | Xencor, Inc. | 1.74B | -0.55% | 1,369,923 | 104.97M |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.72B | -0.98% | 502,793 | 245.82M |
| 274 | TRVI | Trevi Therapeutics, Inc. | 1.72B | -1.87% | 3,038,792 | - |
| 275 | ALHC | Alignment Healthcare, Inc. | 1.71B | -0.84% | 6,760,835 | 4.58B |
| 276 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | 0.31% | 2,743,431 | 208.78M |
| 277 | PSNL | Personalis, Inc. | 1.70B | 0.32% | 3,262,540 | 69.67M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.70B | -0.56% | 430,895 | 481.07M |
| 279 | SEPN | Septerna, Inc. | 1.70B | -0.27% | 369,978 | 98.88M |
| 280 | ARDT | Ardent Health, Inc. | 1.69B | 2.22% | 1,045,228 | 6.41B |
| 281 | XRAY | DENTSPLY SIRONA Inc. | 1.68B | -0.82% | 3,968,952 | 3.64B |
| 282 | BHVN | Biohaven Ltd. | 1.65B | -4.29% | 1,777,668 | - |
| 283 | NUVB | Nuvation Bio Inc. | 1.64B | -0.85% | 3,780,113 | 169.90M |
| 284 | AZTA | Azenta, Inc. | 1.63B | -1.82% | 1,112,839 | 613.81M |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -1.19% | 425,053 | 1.00M |
| 286 | OMCL | Omnicell, Inc. | 1.61B | -2.91% | 385,751 | 1.25B |
| 287 | ATEC | Alphatec Holdings, Inc. | 1.61B | -3.51% | 1,761,130 | 815.05M |
| 288 | NVCR | NovoCure Limited | 1.61B | -3.22% | 1,186,008 | 699.19M |
| 289 | GENB | Generate Biomedicines, Inc. | 1.61B | 2.12% | 1,951,144 | 26.48M |
| 290 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -4.03% | 5,439,154 | 59.51M |
| 291 | OCUL | Ocular Therapeutix, Inc. | 1.58B | -0.55% | 2,208,787 | 52.06M |
| 292 | BRVE | Braveheart Bio, Inc. | 1.58B | 0.05% | 462,847 | - |
| 293 | KRSA | Korsana Biosciences, Inc. | 1.56B | 8.40% | 193,572 | - |
| 294 | CMPS | COMPASS Pathways plc | 1.56B | 1.17% | 2,536,082 | - |
| 295 | GPCR | Structure Therapeutics Inc. | 1.56B | -1.93% | 2,069,294 | - |
| 296 | PAHC | Phibro Animal Health Corporation | 1.54B | 3.04% | 283,079 | 1.52B |
| 297 | KMTS | Kestra Medical Technologies, Ltd. | 1.52B | -5.56% | 237,443 | 106.73M |
| 298 | INVA | Innoviva, Inc. | 1.51B | 1.11% | 673,510 | 440.00M |
| 299 | ETON | Eton Pharmaceuticals, Inc. | 1.51B | -0.84% | 442,519 | 105.60M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.50B | -0.96% | 269,202 | 978.38M |
| 301 | STOK | Stoke Therapeutics, Inc. | 1.50B | 3.38% | 1,089,796 | 27.59M |
| 302 | ABSI | Absci Corporation | 1.50B | -3.96% | 3,557,567 | 1.56M |
| 303 | AGL | agilon health, inc. | 1.47B | 1.75% | 145,322 | 5.92B |
| 304 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -0.13% | 2,955,624 | 717.00M |
| 305 | IMCR | Immunocore Holdings plc | 1.46B | 1.87% | 414,303 | 430.78M |
| 306 | AMN | AMN Healthcare Services, Inc. | 1.46B | 3.07% | 877,197 | 3.43B |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.46B | -1.61% | 835,697 | 20.00M |
| 308 | QURE | uniQure N.V. | 1.45B | -1.46% | 3,331,993 | 18.67M |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.25% | 2,331,861 | 746.16M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.44B | 0.62% | 623,333 | 1.86B |
| 311 | CERT | Certara, Inc. | 1.43B | -2.50% | 1,821,434 | 421.75M |
| 312 | PNTG | The Pennant Group, Inc. | 1.43B | 1.67% | 153,484 | 1.10B |
| 313 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | 0.47% | 224,941 | - |
| 314 | ANAB | AnaptysBio, Inc. | 1.40B | 2.37% | 494,172 | 106.09M |
| 315 | KLRA | Kailera Therapeutics, Inc. | 1.39B | -0.28% | 1,304,811 | - |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.36B | -2.28% | 304,016 | 20.00M |
| 317 | AAPG | Ascentage Pharma Group International | 1.36B | -1.39% | 3,373 | 94.61M |
| 318 | NUTX | Nutex Health Inc. | 1.35B | -3.65% | 125,024 | 846.72M |
| 319 | CNMD | CONMED Corporation | 1.35B | -1.36% | 392,390 | 1.37B |
| 320 | OMER | Omeros Corporation | 1.33B | -2.38% | 905,106 | 38.42M |
| 321 | FRNM | Freenome, Inc. | 1.31B | -3.56% | 657,786 | 35.41M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.29B | 0.75% | 483,998 | - |
| 323 | GHRS | GH Research PLC | 1.27B | -1.54% | 304,385 | - |
| 324 | USPH | U.S. Physical Therapy, Inc. | 1.27B | -0.62% | 119,802 | 804.27M |
| 325 | KARD | Kardigan, Inc. | 1.26B | 4.24% | 826,684 | - |
| 326 | NKTR | Nektar Therapeutics | 1.26B | -2.72% | 1,002,708 | 54.59M |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.25B | -2.09% | 246,809 | 1.30M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.25B | -1.75% | 422,386 | - |
| 329 | INNV | InnovAge Holding Corp. | 1.24B | 0.67% | 357,539 | 989.71M |
| 330 | TRAX | First Tracks Biotherapeutics, Inc. | 1.22B | 7.73% | 982,120 | - |
| 331 | SVRA | Savara Inc. | 1.21B | -0.42% | 2,574,261 | - |
| 332 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21B | -3.01% | 3,040,047 | 252.25M |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 2.48% | 1,791,371 | - |
| 334 | AHG | Akso Health Group | 1.18B | 1.18% | 9,184 | 13.83M |
| 335 | CRON | Cronos Group Inc. | 1.17B | -1.25% | 955,240 | 179.09M |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.15B | -2.03% | 683,469 | 785.23M |
| 337 | IRMD | IRADIMED CORPORATION | 1.15B | 0.20% | 73,504 | 86.34M |
| 338 | BCAX | Bicara Therapeutics Inc. | 1.15B | - | 1,428,697 | - |
| 339 | TSHA | Taysha Gene Therapies, Inc. | 1.14B | -1.96% | 4,342,800 | 5.49M |
| 340 | DMRA | Damora Therapeutics, Inc. | 1.14B | -0.70% | 277,552 | - |
| 341 | BVS | Bioventus Inc. | 1.14B | -0.44% | 338,406 | 581.85M |
| 342 | OMDA | Omada Health, Inc. | 1.12B | -0.44% | 1,636,974 | 309.76M |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | -3.84% | 2,221,716 | 1.04B |
| 344 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | 0.12% | 364,655 | 730.02M |
| 345 | VOR | Vor Biopharma Inc. | 1.11B | -1.63% | 927,175 | - |
| 346 | NBTX | Nanobiotix S.A. | 1.11B | -0.98% | 80,657 | 13.15M |
| 347 | LBRX | LB Pharmaceuticals Inc | 1.10B | -2.27% | 362,715 | - |
| 348 | STAA | STAAR Surgical Company | 1.10B | 1.58% | 552,891 | 339.59M |
| 349 | REPL | Replimune Group, Inc. | 1.07B | -5.95% | 1,864,175 | - |
| 350 | ENOV | Enovis Corporation | 1.07B | -2.21% | 1,142,268 | 2.30B |
| 351 | TDOC | Teladoc Health, Inc. | 1.06B | -3.17% | 3,522,725 | 2.49B |
| 352 | AVLN | Avalyn Pharma Inc. | 1.05B | -0.21% | 267,770 | - |
| 353 | AORT | Artivion, Inc. | 1.05B | 0.80% | 488,611 | 471.47M |
| 354 | JANX | Janux Therapeutics, Inc. | 1.05B | -0.29% | 614,666 | 24.00M |
| 355 | HSTM | HealthStream, Inc. | 1.03B | -0.30% | 199,694 | 321.12M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.02B | -4.87% | 1,105,454 | 1.65B |
| 357 | OPK | OPKO Health, Inc. | 1.02B | 3.79% | 1,635,737 | 587.90M |
| 358 | HROW | Harrow, Inc. | 1.02B | -3.54% | 660,462 | 275.59M |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.01B | -0.47% | 201,767 | 1.04B |
| 360 | CBLL | CeriBell, Inc. | 1.01B | 0.88% | 887,633 | 101.96M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.01B | 0.70% | 243,277 | 357.28M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.00B | -8.32% | 1,725,681 | 337.34M |
| 363 | MNKD | MannKind Corporation | 971.05M | -0.98% | 7,938,734 | 393.63M |
| 364 | IMTX | Immatics N.V. | 956.83M | 2.49% | 1,566,890 | 47.65M |
| 365 | QDEL | QuidelOrtho Corporation | 951.14M | -1.63% | 2,145,923 | 2.67B |
| 366 | LTGO | Latigo Biotherapeutics, Inc. | 928.19M | -10.88% | 222,499 | - |
| 367 | AKTS | Aktis Oncology, Inc. | 917.17M | -0.90% | 621,848 | 10.06M |
| 368 | MGTX | MeiraGTx Holdings plc | 903.76M | -5.33% | 1,104,073 | 397.50M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 892.89M | 3.73% | 208,623 | - |
| 370 | BBNX | Beta Bionics, Inc. | 888.07M | -4.64% | 892,916 | 119.01M |
| 371 | SLBT | SL Science Holding Limited | 883.91M | 1.31% | 30,626 | 3.27M |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 877.80M | -3.26% | 903,555 | - |
| 373 | RIGL | Rigel Pharmaceuticals, Inc. | 874.59M | -0.68% | 160,105 | 276.79M |
| 374 | SIBN | SI-BONE, Inc. | 872.62M | -1.07% | 407,810 | 213.60M |
| 375 | MLTX | MoonLake Immunotherapeutics | 862.98M | -2.59% | 1,772,987 | - |
| 376 | KURA | Kura Oncology, Inc. | 854.91M | -2.24% | 1,825,841 | 77.23M |
| 377 | JBIO | Jade Biosciences, Inc. | 854.75M | 0.15% | 1,172,683 | - |
| 378 | ANRO | Alto Neuroscience, Inc. | 851.95M | -1.72% | 2,281,125 | - |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 839.48M | -0.51% | 1,092,893 | 28.73M |
| 380 | AHCO | AdaptHealth Corp. | 833.81M | -1.26% | 1,824,960 | 3.36B |
| 381 | GMRS | GMR Solutions Inc. | 833.18M | 1.23% | 774,689 | 5.88B |
| 382 | ABUS | Arbutus Biopharma Corporation | 828.98M | 1.95% | 2,433,901 | 181.72M |
| 383 | INMD | InMode Ltd. | 820.83M | -0.21% | 337,647 | 374.63M |
| 384 | AVBP | ArriVent BioPharma, Inc. | 798.79M | 0.68% | 1,589,158 | - |
| 385 | ODTX | Odyssey Therapeutics, Inc. | 795.45M | -3.71% | 245,628 | 99.00K |
| 386 | ARDX | Ardelyx, Inc. | 794.91M | 2.24% | 5,828,761 | 450.89M |
| 387 | SGP | SpyGlass Pharma, Inc. | 792.38M | -0.96% | 49,099 | - |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 789.05M | -0.32% | 976,788 | - |
| 389 | ALMS | Alumis Inc. | 784.38M | -7.62% | 2,298,082 | 7.40M |
| 390 | DNA | Ginkgo Bioworks Holdings, Inc. | 776.43M | -1.96% | 1,763,049 | 132.42M |
| 391 | VREX | Varex Imaging Corporation | 775.10M | -0.43% | 869,972 | 865.00M |
| 392 | GERN | Geron Corporation | 764.54M | -0.83% | 5,428,739 | 204.56M |
| 393 | HELP | Helus Pharma Inc. | 758.36M | -1.14% | 1,054,852 | - |
| 394 | OBX | Obsidian Therapeutics, Inc. | 754.86M | 1.92% | 298,259 | - |
| 395 | COLL | Collegium Pharmaceutical, Inc. | 732.83M | 4.55% | 920,242 | 808.21M |
| 396 | ACHV | Achieve Life Sciences, Inc. | 720.32M | - | 1,642,258 | - |
| 397 | APMD | Apnimed, Inc. | 717.30M | -3.37% | 1,012,796 | 115.12M |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.93M | -0.62% | 1,905,894 | 41.47M |
| 399 | IMMX | Immix Biopharma, Inc. | 705.50M | -2.07% | 1,360,513 | - |
| 400 | CTKB | Cytek Biosciences, Inc. | 701.26M | 0.84% | 1,074,552 | 206.71M |
| 401 | ANL | Adlai Nortye Group Ltd. | 700.65M | -7.48% | 378,006 | 18.06M |
| 402 | IVA | Inventiva S.A. | 700.35M | - | 3,150,656 | 2.81M |
| 403 | VSTM | Verastem, Inc. | 698.24M | 3.49% | 33,757,758 | 87.53M |
| 404 | SANA | Sana Biotechnology, Inc. | 697.51M | -3.32% | 2,766,886 | - |
| 405 | ANNX | Annexon, Inc. | 695.76M | -4.18% | 4,042,922 | - |
| 406 | CADL | Candel Therapeutics, Inc. | 694.02M | -2.16% | 989,443 | - |
| 407 | GYRE | Gyre Therapeutics, Inc. | 686.04M | -3.58% | 162,848 | 109.82M |
| 408 | MDXG | MiMedx Group, Inc. | 685.07M | 0.21% | 1,635,491 | 355.17M |
| 409 | ATTO | Attovia Therapeutics, Inc. | 682.94M | 1.63% | 359,605 | 1.80M |
| 410 | PHAR | Pharming Group N.V. | 677.16M | 2.12% | 3,959 | 366.48M |
| 411 | FDMT | 4D Molecular Therapeutics, Inc. | 673.98M | -1.29% | 632,964 | 92.01M |
| 412 | STLN | Starling Oncology, Inc. | 663.47M | -2.84% | 1,338,684 | 587.24M |
| 413 | OABI | OmniAb, Inc. | 661.53M | -3.19% | 737,808 | 38.46M |
| 414 | PHR | Phreesia, Inc. | 659.81M | -1.12% | 548,363 | 507.79M |
| 415 | AURA | Aura Biosciences, Inc. | 639.86M | -1.59% | 1,009,778 | - |
| 416 | AVTX | Avalo Therapeutics, Inc. | 634.98M | -1.42% | 1,237,161 | 59.00K |
| 417 | PACB | Pacific Biosciences of California, Inc. | 618.55M | -2.93% | 9,205,009 | 159.27M |
| 418 | AVR | Anteris Technologies Global Corp. | 610.31M | -2.95% | 1,740,203 | 2.24M |
| 419 | DSGN | Design Therapeutics, Inc. | 608.92M | -0.51% | 1,046,733 | - |
| 420 | WVE | Wave Life Sciences, Inc. | 608.88M | -1.59% | 2,825,016 | 65.37M |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 607.50M | -1.54% | 752,673 | 136.07M |
| 422 | SOPH | SOPHiA GENETICS SA | 601.00M | -0.42% | 377,446 | 86.17M |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 594.98M | -3.13% | 1,846,220 | - |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 594.86M | 0.28% | 1,223,260 | 389.32M |
| 425 | WEAV | Weave Communications, Inc. | 591.19M | 0.27% | 1,191,540 | 257.79M |
| 426 | CLYM | Climb Bio, Inc. | 591.02M | -0.19% | 987,717 | - |
| 427 | PHAT | Phathom Pharmaceuticals, Inc. | 587.78M | 5.71% | 1,721,072 | 239.66M |
| 428 | NVCT | Nuvectis Pharma, Inc. | 586.47M | -0.83% | 184,200 | - |
| 429 | SLDB | Solid Biosciences Inc. | 585.99M | -6.10% | 2,378,470 | - |
| 430 | KIDS | OrthoPediatrics Corp. | 580.94M | 1.46% | 204,021 | 252.72M |
| 431 | AQST | Aquestive Therapeutics, Inc. | 578.61M | -1.28% | 1,601,519 | 54.09M |
| 432 | FLGT | Fulgent Genetics, Inc. | 578.10M | -0.24% | 352,143 | 323.93M |
| 433 | CRMD | CorMedix Inc. | 576.01M | - | 1,124,916 | 462.25M |
| 434 | ETRA | Electra Therapeutics, Inc. | 561.14M | 3.83% | 521,072 | - |
| 435 | PRME | Prime Medicine, Inc. | 556.84M | -5.72% | 4,236,504 | 4.07M |
| 436 | SSII | SS Innovations International, Inc. | 541.04M | 5.88% | 27,024 | 52.40M |
| 437 | SLN | Silence Therapeutics plc | 540.68M | 1.24% | 1,233,158 | 615.00K |
| 438 | CBIO | Crescent Biopharma, Inc. | 538.44M | -2.56% | 284,782 | 11.88M |
| 439 | SGMT | Sagimet Biosciences Inc. | 535.01M | -5.45% | 1,985,001 | - |
| 440 | STTK | Shattuck Labs, Inc. | 534.94M | -2.91% | 1,202,912 | 1.00M |
| 441 | VALN | Valneva SE | 534.92M | 1.80% | 22,519 | 163.30M |
| 442 | EVH | Evolent Health, Inc. | 534.77M | 2.83% | 2,269,340 | 2.10B |
| 443 | PBYI | Puma Biotechnology, Inc. | 526.52M | 0.79% | 327,036 | 231.24M |
| 444 | DBVT | DBV Technologies S.A. | 525.61M | -1.77% | 351,200 | 5.04M |
| 445 | FTH | Faeth Therapeutics, Inc. | 516.81M | -7.02% | 421,407 | - |
| 446 | EVO | Evotec SE | 515.59M | 5.95% | 158,371 | 819.47M |
| 447 | DCTH | Delcath Systems, Inc. | 510.77M | -3.92% | 231,958 | 95.42M |
| 448 | TCMD | Tactile Systems Technology, Inc. | 507.64M | 0.45% | 159,768 | 350.31M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 450 | ACRS | Aclaris Therapeutics, Inc. | 497.53M | -2.59% | 2,589,455 | 8.22M |
| 451 | MNPR | Monopar Therapeutics Inc. | 490.66M | 1.42% | 129,687 | - |
| 452 | DRUG | Bright Minds Biosciences Inc. | 490.53M | -1.27% | 199,356 | - |
| 453 | MASS | 908 Devices Inc. | 488.98M | -2.15% | 411,605 | 60.84M |
| 454 | CTMX | CytomX Therapeutics, Inc. | 485.92M | -4.09% | 3,354,971 | 18.30M |
| 455 | BLSM | BlossomHill Therapeutics, Inc. | 485.04M | -1.42% | 170,167 | - |
| 456 | EOLS | Evolus, Inc. | 476.88M | -3.86% | 1,007,551 | 316.49M |
| 457 | BWAY | BrainsWay Ltd. | 469.58M | -3.44% | 114,766 | 60.70M |
| 458 | ANGO | AngioDynamics, Inc. | 464.70M | 1.38% | 1,589,717 | 325.38M |
| 459 | TLRY | Tilray Brands, Inc. | 460.52M | -3.98% | 4,672,712 | 963.10M |
| 460 | SGHT | Sight Sciences, Inc. | 454.48M | -1.67% | 304,672 | 83.38M |
| 461 | RGNX | REGENXBIO Inc. | 454.17M | -5.23% | 1,566,808 | 174.48M |
| 462 | NRC | NRC Health | 451.90M | 1.29% | 78,775 | 140.00M |
| 463 | CERS | Cerus Corporation | 451.42M | -0.88% | 2,891,076 | 221.55M |
| 464 | YDES | YD Bio Limited | 450.49M | 4.26% | 20,354 | 1.24M |
| 465 | AUTL | Autolus Therapeutics plc | 449.81M | 4.32% | 2,590,103 | 117.39M |
| 466 | ALT | Altimmune, Inc. | 449.34M | -4.94% | 5,626,995 | 31.00K |
| 467 | ALLO | Allogene Therapeutics, Inc. | 449.14M | 0.78% | 7,736,869 | 4.64M |
| 468 | ARVN | Arvinas, Inc. | 445.93M | -0.29% | 856,960 | 316.70M |
| 469 | PROK | ProKidney Corp. | 444.41M | -6.37% | 2,125,778 | 818.00K |
| 470 | NGNE | Neurogene Inc. | 443.85M | 2.88% | 522,546 | 925.00K |
| 471 | RZLT | Rezolute, Inc. | 443.71M | -8.24% | 1,703,119 | - |
| 472 | OCS | Oculis Holding AG | 442.62M | -5.91% | 517,710 | 1.45M |
| 473 | KMDA | Kamada Ltd. | 437.65M | -1.17% | 59,844 | 191.85M |
| 474 | ENTX | Entera Bio Ltd. | 434.81M | 0.40% | 784,486 | 42.00K |
| 475 | MPLT | MapLight Therapeutics, Inc. | 434.05M | -0.89% | 450,926 | - |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.07M | -1.35% | 278,229 | - |
| 477 | NPCE | NeuroPace, Inc. | 431.11M | -0.95% | 90,023 | 106.99M |
| 478 | PRTA | Prothena Corporation plc | 429.69M | 0.12% | 620,027 | 54.53M |
| 479 | SENS | Senseonics Holdings, Inc. | 428.28M | -9.19% | 726,584 | 48.55M |
| 480 | AGMB | AgomAb Therapeutics NV | 427.96M | -1.36% | 57,698 | - |
| 481 | OVID | Ovid Therapeutics Inc. | 427.70M | - | 1,642,458 | 1.58M |
| 482 | ZURA | Zura Bio Limited | 422.61M | 4.26% | 5,756,297 | - |
| 483 | TKNO | Alpha Teknova, Inc. | 418.23M | -5.23% | 236,354 | 43.70M |
| 484 | ASMB | Assembly Biosciences, Inc. | 418.00M | 0.93% | 241,370 | 74.85M |
| 485 | DMAC | DiaMedica Therapeutics Inc. | 413.07M | -2.05% | 286,962 | - |
| 486 | TECX | Tectonic Therapeutic, Inc. | 409.75M | -1.64% | 190,778 | - |
| 487 | CTEV | Claritev Corporation | 405.72M | 0.93% | 184,318 | 994.67M |
| 488 | RCEL | AVITA Medical, Inc. | 405.14M | -1.95% | 525,638 | 75.63M |
| 489 | CYH | Community Health Systems, Inc. | 403.87M | -0.33% | 826,377 | 11.98B |
| 490 | MYGN | Myriad Genetics, Inc. | 396.95M | 1.72% | 1,860,261 | 806.60M |
| 491 | SCTX | Scribe Therapeutics Inc. | 393.21M | 8.63% | 391,967 | 33.30M |
| 492 | SPRY | ARS Pharmaceuticals, Inc. | 390.83M | -2.96% | 1,729,602 | 116.93M |
| 493 | AUNA | Auna S.A. | 388.57M | -1.50% | 118,659 | 1.37B |
| 494 | CAPR | Capricor Therapeutics, Inc. | 383.14M | -4.22% | 2,517,064 | 11.13M |
| 495 | EIKN | Eikon Therapeutics, Inc. | 379.70M | 4.32% | 595,511 | - |
| 496 | SRTA | Strata Critical Medical, Inc. | 378.64M | -3.82% | 825,046 | 255.98M |
| 497 | CARL | Carlsmed, Inc. | 378.14M | -4.28% | 52,081 | 63.30M |
| 498 | OFIX | Orthofix Medical Inc. | 376.78M | -0.11% | 292,198 | 833.19M |
| 499 | SI | Shoulder Innovations, Inc. | 372.03M | -1.11% | 104,061 | 60.06M |
| 500 | AVIR | Atea Pharmaceuticals, Inc. | 371.35M | -7.03% | 414,460 | - |